Gilead Sciences: Innovative Approaches to Healthcare Can Remove Barriers
Rhea-AI Summary
Gilead Sciences, a biopharmaceutical company focused on developing innovative medicines for unmet medical needs, emphasizes the importance of removing barriers to healthcare access. Johanna Mercier, Chief Commercial Officer, highlights Gilead's efforts to improve health equity and increase access to life-changing therapies. These initiatives align with the company's commitment to responsible business practices.
Gilead operates in over 35 countries globally, with its headquarters in Foster City, California. The company's mission is to transform and simplify care for people with life-threatening illnesses worldwide, focusing on areas of unmet medical need.
Positive
- Global presence in over 35 countries, indicating wide market reach
- Focus on developing innovative medicines for unmet medical needs
- Commitment to improving health equity and increasing access to therapies
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, GILD declined 0.72%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
NORTHAMPTON, MA / ACCESSWIRE / September 4, 2024 / Transformative medicines have the greatest impact when they reach the people who need them most.
Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies - all of which underscore our commitment to being a responsible company.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com